Skip to main content
Search
News, Views, and Advocacy From the Oncology Nursing Society
ONS Voice Home
  • News & Views
  • Advocacy
  • Stories
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS
  • News & Views
    • Latest Articles
    • Clinical Practice
    • ONS News
    • ONS Leadership
    Trending Topics
    • Research
    • Treatments
    • Safety
    • COVID-19
    • Drug Reference Sheet
    • Special Populations
    View All Topics
    Advocacy
    • Latest Articles
    • Updates
    • Get Involved
    Stories View All
    View All
    Two Oncology Nurses Implement Process to Allow Patients to Disconnect Pumps From the Comfort of Their Own Homes
    Chemotherapy
    Two Oncology Nurses Implement Process to Allow Patients to Disconnect Pumps From the Comfort of Their Own Homes
    May 19, 2023
    Innovative Oncology Nurses Break Down Communication Barriers for Patients Who Are Deaf or Hard of Hearing
    Special Populations
    Innovative Oncology Nurses Break Down Communication Barriers for Patients Who Are Deaf or Hard of Hearing
    March 10, 2023
    How I Practice Mindfulness as an Oncology Nurse
    Nurse well-being
    How I Practice Mindfulness as an Oncology Nurse
    March 03, 2023
    Clinical and Pharmaceutical Nurse Educators Collaborate to Bring Training to Nurses and Improve Patient Care
    Oncology nurse education
    Clinical and Pharmaceutical Nurse Educators Collaborate to Bring Training to Nurses and Improve Patient Care
    January 13, 2023
    Oncology Nurse Uses Retirement to Help Patients and Healthcare Professionals Understand Pancreatic Cancer Biomarker Testing Results
    Pancreatic cancer
    Oncology Nurse Uses Retirement to Help Patients and Healthcare Professionals Understand Pancreatic Cancer Biomarker Testing Results
    November 11, 2022
    previous slide
    next slide
    Search
  • News & Views
  • Advocacy
  • Stories
  • Topic

    Research

    Dendritic Cell Vaccine
    Immunotherapy

    Dendritic Cell Vaccine Uses Immune System to Fight NSCLC

    A new study testing a dendritic cell vaccine for the first time in humans to treat non-small cell lung cancer (NSCLC) has shown that it successfully amplifies the immune system to boost the effectiveness of anti-PD-1 immunotherapies against the cancer. The findings were published in Clinical Cancer Research.

    September 20, 2017
    cancer research study finds peak time for cancer risk with brca mutations
    Research

    Study Finds Peak Time for Cancer Risk With BRCA Mutations

    Breast cancer risk peaks when a patient is in her 40s for BRCA1 mutations and in her 50s for BRCA2 mutations, according to the results of a new study published in JAMA.

    September 06, 2017
    oncology clinical trial nurses impact cancer care
    Oncology clinical trials

    Oncology Nurses Drive Change In Cancer Care With Clinical Trials

    Clinical trials are responsible for discovering new treatments for cancer as well as the continued evolution of standards of care in clinical practice. Nationally, less than 5% of all eligible adult patients with cancer enroll in clinical trials. Additionally, it takes a drug an average of six to eight years from when it is first introduced in trials to become fully available to all patients who could benefit from it.

    September 05, 2017
    quality improvement, evidence-based practice and research in oncology
    Evidence-based care

    The Difference Between Quality Improvement, Evidence-Based Practice, and Research

    As healthcare institutions become ever more complex and our focus on patient experience expands, nurses are leading and participating in research studies, evidence-based practice (EBP) projects, and quality improvement (QI) initiatives with a goal of improving patient outcomes. Research, EBP, and QI have subtle differences and frequent overlap, which can make it a challenge for nurses to identify the best option to investigating a clinical problem.

    August 29, 2017
    Immunotherapy Communication
    Immunotherapy

    Patient-Provider Communication on Immunotherapy Can Be Improved

    Guidelines regarding healthcare provider communication about immunotherapy do not currently exist. Researchers sought to determine patient and provider preferences for this type of information and to identify barriers to communication about immunotherapy. The study’s findings were presented at the 2017 ASCO Annual Meeting.

    July 19, 2017
    Health Disparities
    Cancer health disparities

    FDA Funds Research Into Health Disparities

    Disparities continue to create a wide gap in health in the United States. Many factors can contribute to a person’s health, and we still have much to learn about the issue. The U.S. Food and Drug Administration (FDA) has announced it will be dedicating research funding to find out more about how lifestyle impacts health.

    May 19, 2017
    Capitol Roundup
    Health Policy

    Nurse Becomes Acting Surgeon General; Representative Roybal-Allard Calls for Funding Scientific Research; Gottlieb Nomination for FDA Commissioner Sent to Senate

    After former President Obama’s surgeon general was asked to resign by the Trump administration, the White House appointed Rear Admiral Sylvia Trent-Adams, PhD, RN, FAAN, as acting surgeon general.

    May 01, 2017
    cancer research finds significant increase in survival rates
    Research

    Annual Cancer Report Identifies Significant Increases in Survival

    As part of its Annual Report to the Nation on the Status of Cancer for 1975-2014, a group of organizations and agencies identified significant increases in cancer survival in the United States, with survival rates more than doubling for eight cancers.

    April 11, 2017
    FDA Announces Oncology Center of Excellence
    U.S. Food and Drug Administration (FDA)

    FDA Announces Oncology Center of Excellence

    The U.S. Food and Drug Administration (FDA) recently announced, through the Office of Health and Constituent Affairs, that it has established the Oncology Center of Excellence (OCE). Longtime FDA official, Richard Pazdur, MD, has been named to lead the division as its first director. The OCE will make oncology “the first disease area to have a coordinated clinical review of drugs, biologics and devices across the agency’s three medical product centers,” according to the FDA.

    March 02, 2017
    Health Policy

    Palliative Care, Opioids, and Biomarkers Lead NIH's 2016 Research Year in Review

    The National Institutes of Health (NIH) has outlined it 2016 research year in review, detailing work done on atomic imaging for drug and protein interactions, biomarkers for prostate cancer, opioid efficacy, and the importance of palliative care. Often lauded as an example of the positive impact that federal agencies can have on Americans, NIH has received welcome support and funding from both sides of the aisle. The research, clinical trials, treatments, and cures that come out of the NIH are life changing and life saving, and all parties in congress recognize its importance.
    January 18, 2017
    Breast cancer

    Mammography Cutoffs Should Be Based on Individual Health History

    Researchers conducting the largest study to date on screening mammography outcomes have found no evidence to support stopping mammography screenings at a certain age. The findings were presented at the 2016 Radiological Society of North America annual meeting.
    January 17, 2017

    Statin Use May Improve Overall Survival From Multiple Myeloma

    A new study has found that use of statin medications in patients with multiple myeloma was associated with a decreased risk of all-cause and cancer-specific mortality. The findings were published in the Journal of Clinical Oncology.
    January 10, 2017
    Access to Cancer Care

    What Is ONS’s Stance on Handling Chemotherapy While Pregnant, Breastfeeding, or Trying to Conceive?

    One of the questions that ONS commonly receives in the clinical inbox (clinical@ons.org) is whether nurses who are pregnant, breastfeeding, or trying to conceive can safely administer or handle chemotherapy and other hazardous drugs.

    January 05, 2017
    Cancer treatments

    Combination Therapy Shows Promise for Chronic Myeloid Leukemia

    According to the results of a new study published in Science Translational Medicine, a combination regimen consisting of a BCR-ABL tyrosine kinase inhibitor and a B-cell lymphoma 2 inhibitor may one day result in a cure for chronic myeloid leukemia.
    January 03, 2017
    Research

    Oncomicrobiotics May Improve Efficacy of Chemotherapy

    The presence of certain intestinal bacteria types may improve the efficacy of alkylating chemotherapy agents such as cyclophosphamide, according to the results of a new study published in Immunity.
    December 20, 2016
    Lung Cancer

    Smoking Causes Higher Proportion of Cancer Deaths in Southern States

    Researchers looked at the burden of cigarette use across all U.S. states and found that the proportion of cancer deaths from smoking was highest in several Southern states, including Arkansas, Kentucky, Louisiana, Tennessee, and West Virginia.
    December 13, 2016
    Research

    CDC Releases Study on Breast Cancer Rates by Age and Ethnicity

    The Centers for Disease Control and Prevention (CDC) released a study in October 2016 that found breast cancer rates among women have decreased in recent years. However, disparities among races and between age groups still exist.
    December 01, 2016
    Oncology nurse researcher

    NINR Sets Strategic Plan for Nursing Research

    On September 15, 2016, the National Institute of Nursing Research (NINR) released its new strategic plan, “Advancing Science, Improving Lives: A Vision for Nursing Science,” citing forward-thinking research.
    October 06, 2016
    Breast cancer

    Neratinib May Be Effective for HER2-Positive Breast Cancer

    According to the results of a phase II, randomized study published in the New England Journal of Medicine, neratinib may effectively treat women with HER2-positive, hormone receptor-negative breast cancer.
    October 04, 2016
    Lung Cancer

    Weight Gain May Indicate Clinical Benefit in NSCLC

    Increasing weight during treatment may indicate early clinical benefit in patients with non-small cell lung cancer (NSCLC), according to the results of a study published in the Annals of Oncology.
    September 27, 2016
    Cancer treatments

    Inotuzumab Ozogamicin May Improve Survival in ALL

    Researchers have found that a monoclonal antibody called inotuzumab ozogamicin may help more patients with refractory B-cell acute lymphoblastic leukemia (ALL) proceed to stem cell transplantation. The findings were reported in the New England Journal of Medicine.
    September 20, 2016
    Cancer screening

    Metastatic Prostate Cancer Increasing in United States

    The number of new U.S. cases of metastatic prostate cancer increased by 72% from 2004–2013, according to a new study published in Prostate Cancer and Prostatic Diseases.
    September 06, 2016
    Oncology drug research

    Maintenance Treatment May Prolong Progression-Free Survival in Ovarian Cancer

    Although response rates to chemotherapy are high, 90% of ovarian cancers will recur within two years. A new drug called niraparib is under investigation as maintenance treatment between cycles of platinum-based chemotherapy, and findings from phase III trials have shown promise.
    August 23, 2016
    Cancer surgery

    Surgery Prolongs Survival for Patients With NSCLC

    Patients with late-stage non-small cell lung cancer who have surgery have better survival rates than those who don’t, according to the results of a recent study published in the Annals of Thoracic Surgery. The researchers also reported that despite the improved survival from surgery, fewer patients are receiving the treatment.
    August 23, 2016
    Cancer treatments

    Poliovirus May Be Key to Treating Glioblastoma

    A phase I study has shown that a small group of patients with recurrent glioblastoma who received treatment with a modified form of poliovirus showed survival improvement over historical controls. The findings, which were not peer reviewed, were presented at the 2016 American Society of Clinical Oncology annual meeting.
    August 16, 2016
    Cancer treatments

    Pembrolizumab Associated With Long-Term Survival in Advanced Melanoma

    A new study has shown that 40% of patients with previously treated advanced melanoma were alive at three years’ follow-up after initiating treatment with pembrolizumab. The results were presented at the 2016 American Society of Clinical Oncology annual meeting.
    August 09, 2016
    Lung Cancer

    Pretreatment Anemia Predicts Poor Survival From NSCLC

    Patients receiving stereotactic body radiation therapy for early-stage non-small cell lung cancer who have anemia at diagnosis may be more likely to have aggressive disease with poor survival and non-local progression, according to findings from a new study published in the Journal of Thoracic Oncology.
    August 02, 2016
    Oncology drug research

    New Class of Drugs Shows Promise in Treatment-Resistant Prostate Cancer

    Researchers in the United Kingdom are looking at a new class of drugs that attacks cancer indirectly through a network of signals, which may prevent or overcome drug resistance. The findings of the study were published in Cancer Research.
    July 26, 2016
    Adverse events

    Sorafenib Adverse Events May Be More Common in Thyroid Cancer

    Researchers have found that patients receiving sorafenib for differential thyroid cancer are more likely to experience adverse events from the drug, compared to patients with renal or hepatocellular cancers. The findings were published in JAMA Oncology.
    July 19, 2016
    Immunotherapy

    What Nurses Need to Know About Talimogene Laherparepvec for Advanced Melanoma

    A number of different oncolytic immunotherapies are in development for advanced melanoma, one of which is talimogene laherparepvec, a genetically modified recombinant herpes simplex virus type 1.
    July 12, 2016
    Prostate cancer

    Prostate Radiotherapy May Increase Bladder Cancer Risk

    Patients with prostate cancer who undergo radiation treatment, especially brachytherapy, may be at increased risk of bladder cancer more than 10 years later, according to the results of a new study presented at the American Urological Association annual meeting.
    July 12, 2016
    Leukemia

    Blinatumomab May Induce Remission in Patients With Relapsed or Refractory ALL

    About 40% of acute lymphocytic leukemias (ALLs) occur in adults, but those cases are responsible for 80% of ALL’s death rate. Two studies have shown the blinatumomab is effective in inducing remissions in refractory B-cell ALL.
    June 21, 2016
    Pancreatic cancer

    Protein May Offer Drug Target for Pancreatic and Other Cancers

    Renalase, a protein that researchers have found is overexpressed in pancreatic cancer, may be a new key to treating the disease. The findings were reported in Scientific Reports.
    June 07, 2016
    Cancer treatments

    Radiation Plus Chemotherapy Improves Survival From Low-Grade Gliomas

    A new study has shown that patients with grade 2 gliomas who are treated with radiation therapy plus a combination of chemotherapy have better survival than patients treated with radiation alone. The findings were published in the New England Journal of Medicine.
    June 01, 2016
    Cancer treatments

    Proteins Targeting Tumor Microenviroment May Block Metastatic Ovarian Cancer Growth

    Although some patients can be treated with surgery and chemotherapy, eventually most metastatic ovarian cancers become resistant to treatment. New options are needed for patients with advanced ovarian cancer.
    May 24, 2016
    Breast cancer

    Study Links Bladder Cancer Subtype to Breast Cancer

    Researchers have found that a subtype of muscle-invasive bladder cancer shares molecular signatures with some forms of breast cancer, opening the door for new ways of treating the disease. The findings were published in the new journal JCI Insight.
    May 10, 2016
    Cancer treatments

    Low-Dose Metformin May Reduce Risk of Colorectal Adenomas

    In patients who have undergone endoscopic polypectomy, subsequent treatment with low-dose metaformin, a diabetes drug, may reduce the risk of metachronous colorectal adenomas and polyps, according to a new study reported in Lancet Oncology.
    May 03, 2016
    Cancer treatments

    New Treatment Approach May Be Effective for Aggressive Ovarian Cancer

    Approximately 80% of ovarian cancers are classified as a high-grade serous subtype. Because of this, long-term survival rates are usually low. Researchers in a new study have found a treatment approach that may offer promise for this form of ovarian cancer.
    April 26, 2016
    Discarded oncology drugs
    Cancer health policy

    Discarded Excess U.S. Cancer Drugs Cost $1.8 Billion per Year

    Infused cancer drugs that are dosed according to patient weight are often available only in single-size vials. Many patients need only part of a second or third vial, and the remaining drug must be discarded. According to researchers, for the top 20 infused cancer drugs in the United States, this amounts to throwing away $1.8 billion in wasted medication.
    April 19, 2016
    Oncology nurses discuss cancer report
    Cancer research

    Annual Report on the Status of Cancer Released

    Annual cancer deaths have decreased, according to the latest report from the National Cancer Institute on the United States’ cancer status. From 2003—2012, overall rates for men, women, and children from infancy to age 19 have fallen by as much as 2%.
    April 18, 2016
    Oncology patient undergoing breast cancer screening
    Breast cancer

    Imaging Tests Are Overused in Early-Stage Breast Cancer

    As many as 60% of women with early-stage breast cancer may receive unnecessary imaging tests such as computed tomography, bone, and positron-emission tomography scans, researchers reported after a new study. The findings were shared during the American Society of Clinical Oncology Quality Care Symposium in February 2016.
    April 12, 2016
    Cancer screening medical device
    Cancer recurrence

    Missing Radiation Therapy Sessions Increases Risk of Recurrence

    Patients who miss two or more regularly scheduled radiation therapy sessions may be at increased risk of recurrence even if they eventually complete their course of treatment, researchers reported after a recent study.
    April 05, 2016
    Oncology nurses at local community cancer center
    Cancer research

    Academic-Community Partnerships

    The news is peppered with stories of the latest studies of new ways to treat or prevent cancer. What do most of those studies have in common? The majority were conducted in large, academic medical centers, leading many to believe that those institutions are where most patients with cancer are receiving their care.
    April 05, 2016
    Cancer moonshot

    National Cancer Moonshot Initiative Could Learn From Open-Source Data Ideas

    At the 2016 State of the Union Address, President Obama announced a commitment to eliminating cancer by 2020. The “moonshot” is to be led by Vice President Joe Biden, who lost his son to a brain tumor last May. In his statement, Biden acknowledges that there are currently many barriers to cancer research and finding a cure. The Cancer Moonshot will need to come at the problem from many angles in order to be effectual.
    April 01, 2016
    Oncology clinical trials

    More Research Is Needed for Adolescent and Young Adult Cancers

    Many young adults are just coming into their own through their teenage years and into their 20s. They’re attending college or entering the workforce, they’re beginning to form serious relationships, and they’re often coming to terms with what it means to be an adult. Unfortunately, this age group is not immune to cancer diagnoses. In fact, according to the National Cancer Institute (NCI), more than 70,000 adolescent and young adult (AYA) cancer diagnoses happen each year.
    March 31, 2016
    Oncology patient with periodontal disease
    Breast cancer

    Periodontal Disease May Increase Breast Cancer Risk, Especially in Women Who Smoke

    Women who have periodontal disease are at greater risk for breast cancer, especially if they smoke or recently quit smoking, according to a new study published in Cancer Epidemiology, Biomarkers, and Prevention.
    March 22, 2016
    Oncology nurses discusses double masectomy
    Breast cancer

    More Women Are Having Double Mastectomies, AHRQ Finds

    In a February blog post, the Agency for Healthcare Research and Quality (AHRQ) posed and answered some serious questions about breast cancer treatment and national trends.
    March 15, 2016
    A young adult patient with blood cancer
    Cancer health disparities

    Psychological Morbidities Linked to Young Adult Survivors of Blood Cancers

    Adolescent and young adult survivors of blood cancers are suffering from psychological diagnoses of depression, anxiety, and post-traumatic stress (PTS), researchers reported in a recent study published in Cancer.
    March 15, 2016
    An oncology nurse reviewing a patient file
    Cancer risk factors

    Association Found Between Vitamin D Deficiency and Leukemia Risk

    Leukemia rates are two times higher in people living at higher latitudes who are exposed to lower levels of sunlight and are more likely to be vitamin D deficient, according to the results of a recent study published in PLOS One.
    March 08, 2016
    Cancer healthcare advocacy

    President Addresses Precision Medicine at White House Summit

    “You can match a blood transfusion to a blood type...what if matching a cancer cure to our genetic code was just as easy, just as standard? What if figuring out the right dose of medicine was as simple as taking our temperature?”

    March 02, 2016
    • First page « First
    • Previous page
    • …
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Current page 9
    • Page 10
    • Next page
    • Last page Last »
    Trending Topics
    • Research
    • Treatments
    • Safety
    • COVID-19
    • Drug Reference Sheet
    • Special Populations
    • ONS Congress Newscast
    • Clinical practice
    • U.S. Food and Drug Administration (FDA)
    • Health Policy
    View All Topics
     
    Home
    News, Views, and Advocacy From the Oncology Nursing Society
  • Legal Notices
  • Contact Us
  • Conferences
  • Advertising
  • Newsroom
  • Sitemap
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS
  • ONS
  • Oncology Nursing Foundation
  • ONCC
  • © Copyright 2023 Oncology Nursing Society
     
    Back to Top ▲